Pharmaceutical Spending in Fee-for-Service Medicare-Reference-Cited by-同舟云学术

Pharmaceutical Spending in Fee-for-Service Medicare

Published:2022-10-18 Issue:15 Volume:328 Page:1502
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Gellad Walid F.¹²,Hernandez Inmaculada³

Affiliation:

1. Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

2. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania

3. Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2797433/jama_gellad_2022_ed_220084_1665434226.71926.pdf

Reference16 articles.

1. The Inflation Reduction Act is a foot in the door for containing health care costs.;Levitt;JAMA Health Forum,2022

2. Prescription drug spending in fee-for-service Medicare, 2008-2019.;Dusetzina;JAMA

3. A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?;San-Juan-Rodriguez;J Manag Care Spec Pharm,2021

4. Inflation Reduction Act of 2022, HR 5376, 117th Cong (2021-2022). Accessed September 18, 2022. https://www.congress.gov/bill/117th-congress/house-bill/5376/text

5. Montero? A, Kearney? A, Hamel? L, Brodie? M. Americans’ challenges with health care costs. Kaiser Family Foundation. July 14, 2022. Accessed September 18, 2022. https://www.kff.org/health-costs/issue-brief/americans-challenges-with-health-care-costs/

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of competition on reimbursement decisions for cancer drugs in China: an observational study;The Lancet Regional Health - Western Pacific;2024-09

2. Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs: A Narrative Review;Pharmacy;2023-12-17

3. Why Does the Inflation Reduction Act Exclude Expensive Cancer Treatments in Price Negotiations?;JCO Oncology Practice;2023-12-07

4. Associations between the use of a real-time benefit tool and measures related to prescription obtainment found in order type subgroups;Journal of the American Pharmacists Association;2023-11